Who is sponsoring NCT06110455?

NCT06110455 is sponsored by University of Thessaly.

What drugs are being tested in NCT06110455?

Interventions in NCT06110455: Neuromuscular Training exercises, Hip and Knee Muscular Strength exercises.

What condition does NCT06110455 study?

NCT06110455 studies Anterior Knee Pain Syndrome.

Is NCT06110455 still recruiting?

NCT06110455 is currently status unknown. Last updated 31 October 2023.

Last reviewed 2023-10-31 · How we verify

NCT06110455

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Neuromuscular Training Compared to Progressive Resistance Training for Patients With Anterior Knee Pain

Status unknown NA Last updated 31 October 2023

What this trial tests

NA trial testing Neuromuscular Training exercises in Anterior Knee Pain Syndrome in 50 participants. Status unknown.

Timeline

2 February 2023

Primary endpoint
15 December 2023

15 May 2024

Quick facts

Lead sponsor	University of Thessaly
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	50
Start date	2 February 2023
Primary completion	15 December 2023
Estimated completion	15 May 2024
Sites	1 location across Greece

Drugs / interventions tested

Neuromuscular Training exercises
Hip and Knee Muscular Strength exercises

Conditions studied

Anterior Knee Pain Syndrome — all drugs for Anterior Knee Pain Syndrome →

Sponsor

University of Thessaly

Who can join

Adults 18 to 40, female only, with Anterior Knee Pain Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary aim of this randomized control trial is to investigate patients' with anterior knee pain if a neuromuscular training program (NMT) has better results in pain and functionality, than an ordinary progressive resistance training program (PRT). Pain will be measured via a visual analog scale for pain (VAS) and functionality via questionnaires such as Kujala and the Greek version of the Modified Baecke Questionnaire (mBQ) and functional tests such as the Anterior Lunge test, Step up/down, squat, balance and reach test. The secondary aims are to investigate the: 1. Hip and knee muscles strength, which will be measured with the Kinvent K-Push dynamometer. Strength will be measured before and after the rehabilitation programs (at baseline and after 8 weeks of intervention). 2. Balance, will also be measured to see the effects of the NMT program. 3. Kinesiophobia, which will be measured with the Tampa Scale 4. Dynamic Knee Valgus, via the Single Leg Landing and Single Leg Squat tests

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Anterior Knee Pain Syndrome

Currently open trials in the same condition.

NCT06832852 — Which Model of Care is the Most Cost-effective in the Treatment of Musculoskeletal Disorders? · NA · recruiting

Other University of Thessaly trials

Trials by the same sponsor.

NCT07376187 — Digital Physiotherapy for Pediatric Chronic Suppurative Lung Diseases · NA · not yet recruiting
NCT07496151 — The Effectiveness of Neurodevelopmental Treatment (Bobath) and Functional Physiotherapy in Children With Cerebral Palsy. · NA · not yet recruiting
NCT07420309 — Colonoscopy TRaining With or Without Artificial INtelligence Among Endoscopy Residents · NA · recruiting
NCT07341711 — Long-term Adaptations of Skeletal Muscle After Hybrid Training. · NA · not yet recruiting
NCT07380009 — Acceptability and Adherence to Different Dosing Regimens of the Multistrain Probiotic Vivomixx® 460 Neo 9 in Adults Rece · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06110455 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Thessaly
Last refreshed: 31 October 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06110455.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing